Skip to main content
BIOGEN INC. logo

BIOGEN INC. — Investor Relations & Filings

Ticker · BIIB ISIN · US09062X1037 LEI · W8J5WZB5IY3K0NDQT671 US Manufacturing
Filings indexed 1,470 across all filing types
Latest filing 2020-04-23 Interim / Quarterly Rep…
Country US United States of America
Listing US BIIB

About BIOGEN INC.

https://www.biogen.com/

Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2020
2020-04-23 English
FORM 3 SUBMISSION
Director's Dealing
2020-04-22 English
8-K
Regulatory Filings
2020-04-22 English
DEFA14A
Regulatory Filings
2020-04-20 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2020-04-20 English
8-K
Regulatory Filings
2020-04-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.